Barclays’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-34,406
| Closed | -$611K | – | 4641 |
|
|
2018
Q3 | $611K | Buy |
34,406
+29,593
| +615% | +$526K | ﹤0.01% | 2541 |
|
|
2018
Q2 | $66K | Sell |
4,813
-62,830
| -93% | -$862K | ﹤0.01% | 3212 |
|
|
2018
Q1 | $614K | Sell |
67,643
-35,466
| -34% | -$322K | ﹤0.01% | 2140 |
|
|
2017
Q4 | $441K | Buy |
103,109
+103,078
| +332,510% | +$441K | ﹤0.01% | 2184 |
|
|
2017
Q3 | $0 | Sell |
31
-42,177
| -100% | – | ﹤0.01% | 4238 |
|
|
2017
Q2 | $63K | Buy |
42,208
+26,502
| +169% | +$39.6K | ﹤0.01% | 2939 |
|
|
2017
Q1 | $40K | Buy |
15,706
+7,232
| +85% | +$18.4K | ﹤0.01% | 3175 |
|
|
2016
Q4 | $21K | Buy |
8,474
+8,236
| +3,461% | +$20.4K | ﹤0.01% | 3079 |
|
|
2016
Q3 | $1K | Sell |
238
-286
| -55% | -$1.2K | ﹤0.01% | 3869 |
|
|
2016
Q2 | $2K | Buy |
524
+300
| +134% | +$1.15K | ﹤0.01% | 3340 |
|
|
2016
Q1 | $1K | Sell |
224
-361
| -62% | -$1.61K | ﹤0.01% | 3382 |
|
|
2015
Q4 | $2K | Sell |
585
-28,449
| -98% | -$97.3K | ﹤0.01% | 3055 |
|
|
2015
Q3 | $116K | Buy |
29,034
+15,531
| +115% | +$62.1K | ﹤0.01% | 2322 |
|
|
2015
Q2 | $68K | Sell |
13,503
-3,937
| -23% | -$19.8K | ﹤0.01% | 2518 |
|
|
2015
Q1 | $105K | Sell |
17,440
-620
| -3% | -$3.73K | ﹤0.01% | 2496 |
|
|
2014
Q4 | $110K | Buy |
18,060
+13,628
| +307% | +$83K | ﹤0.01% | 2657 |
|
|
2014
Q3 | $26K | Sell |
4,432
-5,845
| -57% | -$34.3K | ﹤0.01% | 3306 |
|
|
2014
Q2 | $63K | Sell |
10,277
-304,060
| -97% | -$1.86M | ﹤0.01% | 2948 |
|
|
2014
Q1 | $7.23M | Buy |
314,337
+312,642
| +18,445% | +$7.19M | 0.01% | 811 |
|
|
2013
Q4 | $17K | Buy |
1,695
+304
| +22% | +$3.05K | ﹤0.01% | 3800 |
|
|
2013
Q3 | $18K | Sell |
1,391
-692
| -33% | -$8.96K | ﹤0.01% | 3514 |
|
|
2013
Q2 | $27K | Buy |
+2,083
| New | +$27K | ﹤0.01% | 3589 |
|